Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sunshine Biopharma Inc. - Common stock
(NQ:
SBFM
)
0.7011
-0.0689 (-8.95%)
Delayed Quote
Updated: 2:35 PM EDT, Oct 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
104,655
Open
0.7800
Bid (Size)
0.7011 (300)
Ask (Size)
0.7239 (200)
Prev. Close
0.7700
Today's Range
0.6715 - 0.7800
52wk Range
0.7730 - 24.30
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
September 24, 2026
Launch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with chemotherapy, radiation therapy and surgery Global ondansetron market projected to reach $2.98 billion by...
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
September 16, 2026
Nanomolar potency against PLpro with broad-spectrum SARS-CoV-2 variants activity Significant dose-dependent suppression of pulmonary viral replication in vivo Strong oral bioavailability and...
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Performance
YTD
-94.5%
-94.5%
1 Month
-37.4%
-37.4%
3 Month
-67.8%
-67.8%
6 Month
-93.6%
-93.6%
1 Year
-95.3%
-95.3%
More News
Read More
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
August 31, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
August 26, 2026
Via
FinancialNewsMedia
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
August 26, 2026
From
MarketNewsUpdates.com
Via
GlobeNewswire
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
August 26, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
August 19, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
August 07, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
August 04, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
July 28, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
July 20, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
June 25, 2026
From
Sunshine Biopharma Inc.
Via
ACCESS Newswire
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
June 01, 2026
Via
ACCESS Newswire
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
May 29, 2026
Via
ACCESS Newswire
Thursday's session: top gainers and losers
↗
May 28, 2026
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
May 28, 2026
Via
Chartmill
Which stocks are gapping on Thursday?
↗
May 28, 2026
Via
Chartmill
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
May 28, 2026
Via
ACCESS Newswire
Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW!
May 26, 2026
Via
AB Newswire
Topics
Artificial Intelligence
ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS® Liver Imaging Advances and Strategic Review Acceleration Fuels Investor Awareness
May 26, 2026
Via
AB Newswire
Stocks Under $1: NXXT, TOON, VRAX, AIM, SBFM on Breakout Watch
May 26, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Intellectual Property
What's going on in today's after hours session
↗
May 21, 2026
Via
Chartmill
Most active stocks in Thursday's session
↗
May 21, 2026
Via
Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
↗
May 21, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
May 21, 2026
Via
Chartmill
Frequently Asked Questions
Is Sunshine Biopharma Inc. - Common stock publicly traded?
Yes, Sunshine Biopharma Inc. - Common stock is publicly traded.
What exchange does Sunshine Biopharma Inc. - Common stock trade on?
Sunshine Biopharma Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sunshine Biopharma Inc. - Common stock?
The ticker symbol for Sunshine Biopharma Inc. - Common stock is SBFM on the Nasdaq Stock Market
What is the current price of Sunshine Biopharma Inc. - Common stock?
The current price of Sunshine Biopharma Inc. - Common stock is 0.7011
When was Sunshine Biopharma Inc. - Common stock last traded?
The last trade of Sunshine Biopharma Inc. - Common stock was at 10/01/26 02:35 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
